GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nuformix NFX.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.11p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in GBP, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−£652,600

FY2016FY2025

Free cash flow

−£614,600

FY2016FY2025

Shareholders' equity

£754,900

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue————£50,000£195,600£535,000£610,000£15,000—
Research and development—£70,900£245,100———————
Operating income−£660,600−£506,400−£892,400−£761,300−£1.3m−£1.4m−£914,100−£834,600−£899,400−£334,000
Net income−£652,600−£3.6m−£859,500−£760,100−£1.1m−£1.3m−£756,400−£1.7m−£1.8m−£286,900
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets£1.0m£970,500£4.4m£4.5m£5.0m£6.0m£5.1m£4.6m£5.0m£324,700
Cash and short-term investments£97,600£20,200£202,600£259,300£464,100£1.7m£543,800£4,300£338,200£4,500
Total liabilities£263,900£255,000£223,000£273,600£237,900£324,600£383,900£819,500£534,000£546,200
Debt——————£75,400£15,100£23,000£187,900
Shareholders' equity£754,900£715,600£4.2m£4.2m£4.7m£5.7m£4.7m£3.8m£4.5m−£221,500
Shares outstanding1,661m801m733m708m609m581m477m461m374m300m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−£614,600−£331,900−£596,200−£433,100−£1.3m−£845,200−£717,800−£299,300−£1.5m£117,500
Capital spending—————−£600−£43,200−£27,400−£101,300−£93,300
Free cash flow−£614,600−£331,900−£596,200−£433,100−£1.3m−£845,800−£761,000−£326,700−£1.6m£24,200

Latest quarters

By quarter end

Sept 2025Mar 2025Sept 2024Mar 2024Sept 2023Mar 2023Sept 2022Mar 2022
Operating income−£283,900−£376,700−£263,800−£242,500−£166,700−£337,600−£423,700−£821,300
Net income−£275,900−£376,700−£3.4m−£242,500−£99,300−£337,600−£422,500−£660,000
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets£1.0m£1.0m£970,500£4.4m£4.4m£4.5m£4.8m£5.0m
Cash and short-term investments£97,600£97,900£20,200£183,500£202,600£259,300£389,800£464,100
Shareholders' equity£754,900£807,700£715,600£4.1m£4.2m£4.2m£4.6m£4.7m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-4.6%-13.6%—
Net income-5.0%-12.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-6.5-0.1-0.7-0.8-0.8-1.8-8.0-0.8-0.9-5.2
Price to sales————18.511.311.32.2105.6—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.